Montel Williams: Israel leads in medical marijuana

October 31, 2011 By ARON HELLER , Associated Press
Emmy Award-winning television personality Montel Williams speaks during an interview with the Associated Press in Jerusalem, Sunday, Oct. 30, 2011. Williams says Israel is at the forefront of providing patient access to medical marijuana. Williams was diagnosed with multiple sclerosis in 1999. He has since been an outspoken advocate of medical marijuana to relieve pain caused by disease. (AP Photo/Sebastian Scheiner)

(AP) -- Emmy Award-winning television personality and patient activist Montel Williams said Sunday he was impressed with Israel's liberal attitude toward medical marijuana, and he believes the U.S. could learn a thing or two from the Jewish state.

Williams was diagnosed with multiple sclerosis in 1999 and he has since been an outspoken advocate of medical marijuana to relieve caused by the disease.

The former host of the popular long-running talk show "The Montel Williams Show" is in Israel on a fact-finding mission to learn about its medicinal cannabis practices. He is meeting with legislators, scientists and physicians.

At the height of his TV career, Williams was one of the most recognizable faces in America alongside fellow daytime TV hosts , Phil Donahue and Geraldo Rivera.

"We need to get out of the dark ages and into the new ages," he told The Associated Press. "Not every patient can use cannabis, but for those who can - why deny it?"

In Israel, certain doctors can approve cannabis prescriptions and disperse them to patients, said Itay Goor-Aryeh, the head of the pain management unit at the Sheba Medical Center in central Israel.

He said that while marijuana use is strictly regulated, many doctors prefer prescribing it to patients who qualify because it is "the lesser of evils."

"Those patients, if they do not get cannabis, they will get morphine-like drugs and other harmful drugs," said Goor-Aryeh. "I think that in many ways, cannabis is tolerated and is less addictive that morphine-based drugs."

Sixteen U.S. states have decriminalized the use of to some extent. Critics claim dispensaries are often no more than fronts.

Williams said that those merely seeking to smoke pot won't go through the lengthy bureaucratic process when they could just "go down the street."

Williams, 55, said he takes cannabis on a daily basis.

"For me, there is nothing else that can do what it does," he said. "It helps me suppress my pain ... When I am not using I am thinking about my pain every 45 seconds."

He said the drug has been "vilified to substantiate the false reason why it was banned in the first place," and that he hoped it would one day become a regular prescription drug.

"There are chemicals within that plant," he said, "and some of the leading science on where and how those chemicals work is being done right here in this country," referring to Israel.

shares

Related Stories

Recommended for you

Cancer drugs' high prices not justified by cost of development, study contends

September 12, 2017
(HealthDay)— Excusing the sky-high price tags of many new cancer treatments, pharmaceutical companies often blame high research and development (R&D) costs.

Non-psychotropic cannabinoids show promise for pain relief

September 4, 2017
Some cancers love bone. They thrive in its nutrient-rich environment while gnawing away at the very substrate that sustains them, all the while releasing inflammatory substances that cause pain—pain so severe that opioids ...

Fentanyl drives rise in opioid-linked deaths in U.S.

August 31, 2017
(HealthDay)—Fentanyl, a synthetic narcotic, is a key player in America's continuing epidemic of opioid-related overdose deaths, two new studies report.

Eating triggers endorphin release in the brain

August 28, 2017
Finnish researchers have revealed how eating stimulates brain's endogenous opioid system to signal pleasure and satiety.

Cholesterol-lowering drugs may fight infectious disease

August 21, 2017
That statin you've been taking to lower your risk of heart attack or stroke may one day pull double duty, providing protection against a whole host of infectious diseases, including typhoid fever, chlamydia, and malaria.

Data revealed under FOI shows benefits of multiple sclerosis drug currently blocked by regulators

August 17, 2017
A drug that is blocked by the EU regulatory system has now been found to improve the quality of life of people with multiple sclerosis (MS), according to a study by Queen Mary University of London (QMUL).

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.